At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
The EmStop Embolic Protection System (EmStop System)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Controlled Arterial Protection to Ultimately Remove Embolic Material
In Brief
A clinical study evaluating The EmStop Embolic Protection System (EmStop System) for Aortic Valve Stenosis. Completed, enrolled 15 participants across 2 sites.
Detailed Summary
The objective of this study is to demonstrate device feasibility, safety and investigate performance of the EmStop Embolic Protection System when used as indicated in 15 subjects at 2 investigational sites in the U.S.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis
CountriesUnited States
CollaboratorsBright Research Partners
Timeline
N/ACompletedFinished
202420252026
First PostedOct 2023
Enrollment StartDec 2023
Primary CompletionSep 2024
Study CompletionOct 2024
TodayJul 2026
First PostedOct 27, 2023
Enrollment StartDec 27, 2023
Primary CompletionSep 4, 2024
Study CompletionOct 14, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.7 years ago
Interventions
The EmStop Embolic Protection System (EmStop System)device
The EmStop Embolic Protection System (EmStop System) is a catheter-based filter system that captures and removes debris dislodged during transcatheter aortic valve replacement (TAVR) procedures.